Search for Clinical Trial Results

Sponsored By

Hepatolenticular Degeneration - 16 Studies Found

Status Study
Completed Study Name: Single Daily Dosage of Trientine for Maintenance Treatment for Wilson Disease
Condition: Wilson Disease
Date: 2011-11-11
Interventions: Drug: Once a day Trientine Trientine at a dosage of ~15 mg/kg rounded upwards to the nearest 250 or 300
Active, not recruiting Study Name: The Assessment of Copper Parameters in Wilson Disease Subjects on Standard of Care Treatment
Condition: Wilson Disease
Date: 2016-05-03
Completed Study Name: Efficacy and Safety, Long-term Study of Zinc Acetate to Treat Wilson's Disease in Japan.
Condition: Wilson's Disease
Date: 2005-09-13
Interventions: Drug: NPC-02 zinc acetate
Active, not recruiting Study Name: Efficacy and Safety Study of WTX101 in Adult Wilson Disease Patients
Condition: Wilson Disease
Date: 2014-10-20
Interventions: Drug: WTX101 Dosage Form: 15 mg Tablets
Recruiting Study Name: sCD163 and sMR in Wilsons Disease - Associations With Disease Severity and Fibrosis
Condition: Wilsons Disease
Date: 2016-02-26
Interventions:
  • Procedure: Fibroscan Liver fib
Completed Study Name: A Phase 1 Study to Assess the Effects in the Body of a Single Dose of Trientine Dihydrochloride in Wilson's Disease Patients
Condition: Wilson's Disease
Date: 2013-06-06
Interventions: Drug: trientine dihydrochloride Patients will take their normal prescribed dose (x1) of trientine dihydr
Recruiting Study Name: Study to Assess Long-Term Outcomes of Trientine in Wilson Disease Patients Withdrawn From Therapy With d-Penicillamine
Condition: Wilson Disease
Date: 2014-09-18
Interventions: Drug: trientine dihydrochloride A retrospective review of patients' medical records
Completed Study Name: Study of Zinc for Wilson Disease
Condition: Wilson Disease
Date: 1999-10-18
Interventions: Drug: zinc acetate
Completed Study Name: Study of Tetrathiomolybdate in Patients With Wilson Disease
Condition: Wilson Disease
Date: 1999-10-18
Interventions:
  • Drug: tetrathiomolybdate
  • Drug: trientine
Completed Study Name: Efficacy of Invitro Expanded Bone Marrow Derived Allogeneic Mesenchymal Stem Cell Transplantation Via Portal Vein or Hepatic Artery or Peripheral Vein in Patients With Wilson Cirrhosis
Condition: Wilson's Disease
Date: 2011-06-20
Interventions: Genetic: allogeneic mesenchymal stem cell transplantation 1.000.000(one million) cells/kg, IV (1/2 of do
Next >>>